成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Upadacitinib hemihydrate

Upadacitinib hemihydrate Struktur
2050057-56-0
CAS-Nr.
2050057-56-0
Englisch Name:
Upadacitinib hemihydrate
Synonyma:
Upadacitinib hemihydrate;ABT494 hemihydrate;ABT 494 hemihydrate;ABT-494 hemihydrate;Upadacitinib Hydrate;Cinchonanium, 1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'- [[3-(trifluoromethyl)phenyllmethyl},bromide(1:2), (8a,9R)-";1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-
CBNumber:
CB29872273
Summenformel:
C17H21F3N6O2
Molgewicht:
398.39
MOL-Datei:
2050057-56-0.mol

Upadacitinib hemihydrate Eigenschaften

InChIKey
VJSRYIXHEWRBKD-NFGOAHBONA-N
SMILES
C([C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1C1=CN=C2C=NC3NC=CC=3N12)C.O |&1:1,13,r|

Sicherheit

Upadacitinib hemihydrate Chemische Eigenschaften,Einsatz,Produktion Methoden

Clinical Use

RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate. Each prolonged-release tablet (RINVOQ 15 mg prolonged-release tablets.) contains upadacitinib hemihydrate, equivalent to 15 mg of upadacitinib.

Upadacitinib hemihydrate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Upadacitinib hemihydrate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 79)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TAIZHOU YUXIN BIOTECHNOLOGY CO,.LTD
+86-576-88902229;+86-0576-88902229 +8613968687450
yuxin@yuxchem.com China 167 58
Taizhou Creating Bio-pharm co., ltd.
+8613586099526
post@creatingbiopharm.com China 217 58
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
+86-18600796368 +86-18600796368
sales@sjar-tech.com China 375 58
Binzhou Lista Trading Limited

sallychris2021@gmail.com China 74 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 49374 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471
sales@sarms4muscle.com China 10473 58
Heading (Nanjing)Pharmtechnologies Co., Ltd.
+86-25-58467899-832 +86-13382406280
liucheng@headingpharm.com China 46 58
ShenZhen Trendseen Biological Technology Co.,Ltd.
13417589054
trendseenbio@gmail.com China 11681 58
SUZHOU SENFEIDA CHEMICAL CO.,LTD
+86-0512-83500002 +8615195660023
sales@senfeida.com China 23046 58
Jiangxi Chiyan Biopharmaceutical Technology Co.,Ltd.
+86-18616643091 +86-18616643091
info@rochipharma.com China 246 58

  • 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-
  • Upadacitinib hemihydrate
  • Upadacitinib Hydrate
  • Cinchonanium, 1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'- [[3-(trifluoromethyl)phenyllmethyl},bromide(1:2), (8a,9R)-"
  • ABT 494 hemihydrate
  • ABT494 hemihydrate
  • ABT-494 hemihydrate
  • 2050057-56-0
  • API
Copyright 2019 ? ChemicalBook. All rights reserved